PubMed Health⌕ Search

Biomedical subjects

W Lingnau

Publications and source records attributed to W Lingnau.

25 records · Page 2Linked to original sources
PubMed1993

Comparison of mask and nasal continuous positive airway pressure after extubation and mechanical ventilation.

OBJECTIVE: To examine the effects of continuous positive airway pressure applied via face masks and nose masks on the change in functional residual capacity and gas exchange. DESIGN: Descriptive and prospective study. SETTING: Intensive care unit of a university hospital. PATIENTS: Ten patients with acute lung injury who had required mechanical ventilation. INTERVENTIONS: Continuous positive airway pressure at a level of 10 cm H2O applied in random order via face and nose masks. MEASUREMENTS AND MAIN RESULTS: Both continuous positive airway pressure methods resulted in an almost identical increase of functional residual capacity. During nasal continuous positive airway pressure, the increase in functional residual capacity was 294 +/- 82 mL. During mask continuous positive airway pressure, the increase in functional residual capacity was 290 +/- 85 mL. PaO2 increased and the alveolar-arterial oxygen tension/alveolar oxygen tension quotient decreased significantly during mask continuous positive airway pressure and nasal continuous positive airway pressure at a level of 10 cm H2O. Two patients showed a periodic change in their breathing patterns; they took a few breaths at an increased lung volume, followed by one deep expiration caused by mouth opening. Change in mask pressure was negligible in these two patients. Using a visual analog scale (10 = highly comfortable; 0 = severely uncomfortable), the patients rated nasal continuous positive airway pressure (8.6 +/- 0.9) significantly more comfortable than mask continuous positive airway pressure (2.6 +/- 0.8). CONCLUSION: The major advantages of continuous positive airway pressure (the improvement of functional residual capacity and oxygen transfer) can also be achieved with nasal continuous positive airway pressure in the postextubation period in patients who have been mechanically ventilated for acute lung injury.

Acute Disease↗
PubMed1992

Plasma lignocaine concentrations associated with extradural analgesia in patients with and without multiple organ failure.

We have measured plasma concentrations of lignocaine after thoracic extradural analgesia with continuous infusion of lignocaine in eight intensive care patients with chest wall trauma or after major upper abdominal surgery. Four patients developed multiple organ failure (MOF). Plasma concentrations of lignocaine in arterial blood were measured 4, 8, 24 and 48 h after a continuous infusion of lignocaine was commenced in the extradural space. Plasma concentrations of lignocaine were greater in all patients with MOF (range 2.7-5.1 micrograms ml-1) than in patients without MOF (range 0.8-1.2 micrograms ml-1). Because plasma concentrations in patients with MOF were within the low toxic range, extradural infusion of lignocaine should only be considered in intensive care patients without MOF or when plasma concentrations of lignocaine are monitored.

Adult↗
PubMed1992

Comparison of postoperative respiratory function after laparoscopy or open laparotomy for cholecystectomy.

Cholecystectomy performed via laparotomy is associated with reduction of lung volumes including functional residual capacity that may lead to postoperative hypoxia and atelectasis. Laparoscopic cholecystectomy is associated with faster recovery compared to open laparotomy and cholecystectomy. To determine whether laparoscopic cholecystectomy was associated with less pulmonary dysfunction, 20 patients (ASA Physical Status I) undergoing elective cholecystectomy were randomly assigned to surgical teams performing either laparoscopy or open laparotomy for cholecystectomy. Patients in whom one or the other surgical technique had to be performed for medical or psychologic indications were excluded from the study. A standardized anesthetic technique and postoperative analgesic regimen were used. Forced vital capacity and forced expiratory volume in 1 s; functional residual capacity determined by a closed-circuit, constant volume helium dilution technique; and arterial O2 and CO2 tensions were measured preoperatively and at 6, 24, and 72 h postcholecystectomy. Forced vital capacity and forced expiratory volume in 1 s were significantly greater (P less than 0.05) in the laparoscopy compared to the laparotomy group at 6, 24, and 72 h postoperatively. Forced vital capacity relative to preoperative values was significantly (P less than 0.05) greater in patients with laparoscopy (24 h, 70 +/- 14%; 72 h, 91 +/- 6%) compared to open laparotomy (24 h, 57 +/- 23%; 72 h, 77 +/- 14%). Similarly, forced expiratory volumes in 1 s relative to preoperative values were significantly (P less than 0.05) greater in patients with laparoscopy (24 h, 85 +/- 13%; 72 h, 92 +/- 9%) compared to open laparotomy (24 h, 54 +/- 22%; 72 h, 77 +/- 11%).(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗
PubMed1992

Atrial natriuretic factor release during hypovolemia and after volume replacement.

OBJECTIVE: To examine plasma atrial natriuretic factor activity during hypovolemia and after vascular volume replacement. DESIGN: Prospective, descriptive study. SETTINGS: Scene of emergency, Emergency Department, and the ICU of a university hospital. PATIENTS: A total of 47 trauma patients with evidence of hypovolemia were grouped according to their major injury into a thoracic injury group (15 patients; mean Injury Severity Score = 38.5 +/- 3.1 [SEM], Hospital Trauma Index = 14.1 +/- 0.7), an abdominal injury group (14 patients; Injury Severity Score = 36 +/- 3.3, Hospital Trauma Index = 14 +/- 0.9), and a severe head injury group (18 patients; Injury Severity Score = 23 +/- 1.5, Hospital Trauma Index = 10 +/- 0.6). MEASUREMENTS AND MAIN RESULTS: Measurements were taken at the scene of emergency; after volume replacement in the Emergency Department; and after 3, 7, 12, 24, 36 hrs and on day 5 in the ICU. In all groups, the average plasma atrial natriuretic factor levels were increased at the scene of emergency and declined significantly to normal values with volume replacement. In the thoracic injury group, plasma atrial natriuretic factor activity decreased from 253 +/- 73 to 115 +/- 83 pg/mL (p less than .0017); in the abdominal injury group, plasma atrial natriuretic factor activity decreased from 194 +/- 42 to 91 +/- 24 pg/mL (p less than .006); in the severe head injury group, plasma atrial natriuretic factor activity decreased from 167 +/- 28 to 70 +/- 13 pg/mL (p less than .02) with volume replacement. Plasma atrial natriuretic factor levels at the scene of emergency were significantly (252 +/- 73 vs. 167 +/- 28 pg/mL; p less than .05) higher in the thoracic injury group and in the abdominal injury group (194 +/- 42 vs. 167 +/- 28 pg/mL; p less than .05), as compared with the severe head injury group. CONCLUSIONS: In trauma patients, plasma atrial natriuretic factor concentrations were markedly increased in patients with untreated hypovolemia and were decreased to normal values with vascular volume replacement. Thus, atrial natriuretic factor seems to play an important physiologic role during hypovolemia.

Abdominal Injuries↗
PubMedDate not supplied

In vitro susceptibility of Candida albicans, Austria 1992.

A total of 38 isolates of Candida albicans were collected from clinical specimens and tested for minimum inhibitory concentrations (MICs) and minimum fungicidal concentrations (MFCs) of amphotericin B, flucytosine and fluconazole. For amphotericin B and flucytosine all patients had isolates with MICs < or = 2 micrograms ml-1 and < or = 8 micrograms ml-1 respectively. For fluconazole all but two isolates had MICs < or = 16 micrograms ml-1. In vitro susceptibility testing remains problematic since standardized methods have not been established and the susceptibility and resistance ranges of MIC/MFC values still have to be defined in relation to in vivo data. Nevertheless, these results indicate that topical application of amphotericin B (more than 1 kg of amphotericin B per year at an intensive care unit performing selective digestive tract decontamination on certain trauma patients) had no major impact on the resistance patterns of C. albicans. In contrast, in this study both fluconazole-resistant isolates were from AIDS patients who were known to have received fluconazole therapy. Treatment with fluconazole--quite common in patients with AIDS--may produce resistant fungal isolates.

Amphotericin B↗